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One Sentence Summary: Phase-separated condensates compartmentalize the transcription apparatus at key cell identity genes.
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Super-enhancers (SEs) are clusters of enhancers that cooperatively assemble a high density of 
transcriptional apparatus to drive robust expression of genes with prominent roles in cell identity. 
Here, we demonstrate that the SE-enriched transcriptional coactivators BRD4 and MED1 form 
nuclear puncta at SEs that exhibit properties of liquid-like condensates and are disrupted by 
chemicals that perturb condensates. The intrinsically disordered regions (IDRs) of BRD4 and 
MED1 can form phase-separated droplets and MED1-IDR droplets can compartmentalize and 
concentrate transcription apparatus from nuclear extracts. These results support the idea that 
coactivators form phase-separated condensates at SEs that compartmentalize and concentrate the 
transcription apparatus, suggest a role for coactivator IDRs in this process, and offer insights into 
mechanisms involved in control of key cell identity genes.
Phase separation of fluids is a physicochemical process by which molecules separate into a 
dense phase and a dilute phase. Phase-separated biomolecular condensates, which include 
the nucleolus, nuclear speckles, stress granules, and others, provide a mechanism to 
compartmentalize and concentrate biochemical reactions within cells (1–3). Biomolecular 
condensates produced by liquid-liquid phase separation allow rapid movement of 
components into and within the dense phase and exhibit properties of liquid droplets such as 
fusion and fission (4). Dynamic and cooperative multivalent interactions among molecules, 
such as those produced by certain intrinsically disordered regions of proteins, have been 
implicated in liquid-liquid phase separation (5–7).
Enhancers are gene regulatory elements bound by transcription factors and other 
components of the transcription apparatus that function to regulate expression of cell type-
specific genes (8–13). Super-enhancers (SEs), clusters of enhancers that are occupied by 
exceptionally high densities of transcriptional machinery, regulate genes with especially 
important roles in cell identity (14, 15). DNA interaction data show that enhancer elements 
in the clusters are in close spatial proximity with each other and the promoters of the genes 
they regulate (16–18), consistent with the notion of a dense assembly of transcriptional 
machinery at these sites. This high-density assembly at SEs has been shown to exhibit sharp 
transitions of formation and dissolution, forming as the consequence of a single nucleation 
event (19, 20) and collapsing when concentrated factors are depleted from chromatin (21–
25) or when nucleation sites are deleted (26–29). These properties of SEs led to the proposal 
that the high-density assembly of biomolecules at active SEs is due to phase separation of 
enriched factors at these genetic elements (30). Here, we provide experimental evidence that 
the transcriptional coactivators BRD4 and MED1 form condensates at SEs. This establishes 
a new framework to account for the diverse properties described for these regulatory 
elements and expands the biochemical processes regulated by phase separation to include 
cell identity gene control.
BRD4 and MED1 coactivators form nuclear puncta
The enhancer clusters comprising SEs are occupied by master transcription factors and 
unusually high densities of factors, including BRD4 and MED1, which are coactivators (31–
35) whose presence can be used to define SEs (14, 15, 21). We reasoned that if BRD4 and 
MED1, a subunit of the Mediator complex, are components of nuclear condensates, then 
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they might be visualized as discrete puncta in the nuclei of cells and the properties of these 
puncta could be investigated. Fixed cell immunofluorescence (IF) with antibodies against 
BRD4 and MED1 in murine embryonic stem cells (mESC) revealed nuclear puncta for both 
factors (Fig. 1A). To determine whether such puncta occur in live cells, mESCs were 
engineered using CRISPR/Cas9 to tag endogenous BRD4 and MED1 with mEGFP (Fig. 
S1). Live cell fluorescence microscopy of these engineered mESCs lines also revealed 
discrete nuclear puncta (Fig. 1B). Analysis of these images revealed that there were 1034 
± 130 (SEM) BRD4 and 983 ± 102 (SEM) MED1 puncta per nucleus (Table S1). These 
results demonstrate that BRD4 and MED1 are components of puncta within the nuclei of 
mESCs.
Super-enhancers are associated with coactivator puncta
Several lines of evidence suggest that SEs are likely to be associated with some of the BRD4 
and MED1 puncta in mESCs. ChIP-seq data for BRD4 and MED1 show that SEs are 
especially enriched in these coactivators (14, 15). DNA interaction data suggests that SE 
constituents occupied by BRD4 and MED1 are in close spatial proximity to one another 
(Fig. 1C, Fig. S2A). Co-occupancy of the genome by BRD4 and MED1 is most evident at 
SEs (Fig. S2B) (14, 15). To determine if SEs are associated with some of the BRD4 and 
MED1 puncta, we performed IF for BRD4 or MED1 together with DNA-FISH or nascent 
RNA-FISH for the genomic region containing the Nanog gene and its super-enhancers (Fig. 
1D–G). We found that BRD4 and MED1 puncta consistently overlapped the DNA-FISH foci 
(Fig. 1D) or RNA-FISH foci (Fig. 1F). An average image analysis (see methods for details) 
of BRD4 or MED1 IF signal centered at DNA-FISH foci (N=137 for BRD4 and N=125 for 
MED1) or RNA-FISH foci (N=121 for BRD4 and N=181 for MED1) revealed that, on 
average, BRD4 and MED1 fluorescence intensities are most enriched at the center of FISH 
foci (Fig. 1E, 1G); this trend was not observed for average images centered at randomly 
selected nuclear positions (Fig. 1E, 1G). Radial distribution functions of the averaged 
images for FISH and IF pairs show a significant correlation (Spearman correlation 
coefficients > 0.6, p-values < 1×10−16), with both BRD4 and MED1 having highest signal 
intensity at the center of the FISH focus, decaying with distance from this center (Fig. S3). 
The radial distributions of FISH and IF at randomly selected nuclear positions do not show a 
correlation (Spearman correlation coefficients < 0.2) (Fig. S3). Similar results were obtained 
when we performed IF for BRD4 or MED1 together with nascent RNA-FISH for the SE-
regulated genes Klf4, Mir290, and Trim28 (Fig. S3 and S4A–F). When a similar experiment 
was conducted for two genes expressed in mESCs but not associated with a SE (Fam168b 
and Zfp606), there was no evident overlap between FISH foci and BRD4 puncta (Fig. S4G). 
These results indicate that both BRD4 and MED1 puncta are present at SEs.
Coactivator puncta exhibit liquid-like rates of fluorescence recovery after 
photobleaching
We next sought to examine whether BRD4 and MED1 puncta exhibit features characteristic 
of liquid-like condensates. A hallmark of liquid-like condensates is internal dynamical 
reorganization and rapid exchange kinetics (1–3), which can be interrogated by measuring 
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the rate of fluorescence recovery after photobleaching (FRAP). To study the dynamics of 
BRD4 and MED1 foci in live cells, we performed FRAP experiments on endogenously 
tagged mEGFP-BRD4 or mEGFP-MED1 cell lines. After photobleaching, mEGFP-BRD4 
and mEGFP-MED1 puncta recovered fluorescence on a time-scale of seconds (Fig. 2A–2D), 
with approximate apparent diffusion coefficients of 0.37 ± 0.13 μm2/s and 0.14 ± 0.04 
μm2/s, respectively. These values are similar to previously described components of liquid-
like condensates (36, 37). ATP has been implicated in promoting condensate fluidity by 
driving energy-dependent processes and/or through its intrinsic hydrotrope activity (38, 39). 
Depletion of cellular ATP by glucose deprivation and oligomycin treatment altered 
fluorescence recovery after photobleaching for both mEGFP-BRD4 and mEGFP-MED1 
foci, with the rate of recovery for MED1 reduced and the extent of recovery for BRD4 
diminished (Fig. 2E–2H). These results indicate that puncta containing BRD4 and MED1 
have liquid-like properties in cells, consistent with previously described phase-separated 
condensates.
Coactivator puncta and super-enhancer occupancy are sensitive to 
condensate perturbation
To further investigate the biophysical properties of BRD4 and MED1 puncta, we 
investigated their sensitivity to 1,6-hexanediol, a compound known to disrupt liquid-like 
condensates, putatively through the disruption of hydrophobic interactions (40). We found 
that treatment of mESCs expressing endogenously tagged mEGFP-BRD4 or mEGFP-MED1 
with 1,6-hexanediol caused a reduction in the number of BRD4 and MED1 puncta (Fig. 3A, 
B).
To determine the effect of 1,6-hexanediol on BRD4, MED1 and RNA polymerase II 
(RNAPII) occupancy at enhancers and genes, ChIP-seq was performed with antibodies 
against these proteins in untreated or 1,6-hexanediol-treated mESCs. The results showed that 
1,6-hexanediol treatment caused a reduction in all three proteins at enhancers, with the most 
profound effects occurring at super-enhancers (Fig. 3C, 3D, S5A). For example, at the Klf4 
super-enhancer, the levels of BRD4 were reduced by 44%, those of MED1 by 80% and those 
of RNA polymerase II by 56% upon 1,6-hexanediol treatment (Fig. 3C). Similar effects were 
observed genome-wide, where reductions in BRD4, MED1, and RNAPII were substantially 
larger at super-enhancers than typical enhancers (Fig. 3D) and the degree to which BRD4 
and MED1 were lost from SEs was positively correlated (Fig. S5B). These results are 
consistent with the notion that BRD4 and MED1 form condensates at super-enhancers that 
are sensitive to 1,6-hexanediol.
The level of RNAPII occupancy across gene bodies can be used as a measure of 
transcriptional output (41). The ChIP-seq data revealed that the reduction of BRD4 and 
MED1 occupancy at SEs was associated with a loss of RNAPII occupancy across SE-
associated gene bodies (Fig. 3C, E, and S5A). When genes were ranked by the extent to 
which RNAPII was lost upon 1,6-hexanediol treatment, SE-associated genes were highly 
enriched among those that lost the most RNAPII (Fig. 3F). These results are consistent with 
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the idea that BRD4 and MED1 condensates are associated with super-enhancers and the 
notion that loss of condensate integrity adversely affects transcription.
Intrinsically disordered regions of BRD4 and MED1 phase separate in vitro
BRD4 and MED1 contain large intrinsically disordered regions (IDRs) (Fig. 4A) and share 
features with the IDRs of several proteins known to facilitate condensate formation (2, 3), 
including high proline and glutamine content (BRD4), high serine content (MED1), and 
acidic and basic regions (BRD4 and MED1). The purified IDRs of several proteins involved 
in condensate formation form phase-separated droplets in vitro (36, 37, 42, 43), so we 
investigated whether the IDRs of BRD4 or MED1 form such droplets in vitro. Purified 
recombinant mEGFP-IDR fusion proteins (BRD4-IDR and MED1-IDR) (Fig. 4B) were 
added to buffers containing 10% PEG-8000 (see materials and methods), turning the 
solution opaque, while equivalent solutions with mEGFP alone remained clear (Fig. 4C). 
Fluorescence microscopy of the opaque MED1-IDR and BRD4-IDR solutions revealed 
GFP-positive, micron-sized spherical droplets freely moving in solution (Movies S1 and S2) 
and falling onto and wetting the surface of the glass coverslip, where the droplets remained 
stationary (Movie S3). As determined by aspect ratio analysis, the MED1-IDR and BRD4-
IDR droplets were highly spherical (Fig. S6A), a property expected for liquid-like droplets 
(1–3).
Phase-separated droplets typically scale in size according to the concentration of 
components in the system (44). We performed the droplet formation assay with varying 
concentrations of BRD4-IDR, MED1-IDR, and mEGFP ranging from 0.625μM to 20μM. 
BRD4-IDR and MED1-IDR formed droplets with concentration-dependent size 
distributions, whereas mEGFP remained diffuse in all conditions tested (Fig. 4D and S6B). 
Although these droplets were smaller at lower concentrations, we observed BRD4-IDR and 
MED1-IDR droplets at the lowest concentration tested (0.625μM) (Fig. S6C).
To investigate the biophysical properties of these droplets we tested their ability to form 
droplets under varying salt concentrations (to probe the contribution of electrostatic 
interactions) or upon 1,6-hexanediol (to probe the contribution of hydrophobic interactions). 
The size distributions or opacity of both BRD4-IDR and MED1-IDR droplets shifted toward 
smaller droplets with increasing NaCl concentration (from 50mM to 350mM) (Fig. 4E, 
S6D) or in 10% 1,6-hexanediol (S7A). These results demonstrate that a variety of molecular 
interactions contribute to BRD4-IDR and MED1-IDR droplet formation.
We next sought to test whether the droplets are irreversible aggregates or reversible phase-
separated condensates. To do this, BRD4-IDR and MED1-IDR were allowed to form 
droplets in an initial solution. The protein concentration was then diluted by half in 
equimolar salt or in a higher salt solution (Fig. 4F). The pre-formed droplets of both BRD4-
IDR and MED1-IDR were reduced in size and number with dilution and even further 
reduced with elevated salt concentration (Fig. 4F, Fig. S7B). These results show that the 
BRD4-IDR and MED1-IDR droplets form a distribution of sizes dependent on the 
conditions of the system and, once formed, respond to changes in the system, with rapid 
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adjustments in size. These features are characteristic of phase-separated condensates formed 
by networks of weak protein-protein interactions (1–3).
MED1-IDR participates in liquid-liquid phase separation in cells
To investigate whether the coactivator IDRs facilitate phase separation in cells, we used a 
previously developed assay to manipulate local protein concentrations within the cell; this 
optoIDR assay tests IDR-dependent, light-inducible droplet formation in vivo (45). Briefly, 
the photo-activatable, self-associating Cry2 protein was labeled with mCherry and fused to 
an IDR of interest. This fusion mediates a blue light-inducible increase in local 
concentration of selected IDRs within the cell (Fig. 5A) (45). In this assay, IDRs known to 
promote phase separation enhance the photo-responsive clustering properties of Cry2, 
causing rapid formation of liquid-like spherical droplets upon blue light-stimulation (46, 47). 
Fusion of a portion of the MED1 IDR to Cry2-mCherry facilitated the rapid formation of 
micron-sized spherical droplets upon blue light-stimulation (optoDroplets) (Fig. 5B, C, S8). 
During blue light-stimulation, proximal droplets were observed to fuse (Fig. 5D, 5E and 
Movie S4). The fusions exhibited characteristic liquid-like fusion properties of necking and 
relaxation to spherical shape (Fig. 5E). The MED1-IDR droplets persisted after blue light-
stimulation and exhibited liquid-like FRAP recovery rates in the absence of blue light-
stimulation (Fig. 5F–H). The rapid FRAP kinetics in the absence of light-activated Cry2 
interactions suggests that the MED1-IDR optoDroplets established by blue light are dynamic 
assemblies exchanging with the dilute phase.
Conserved serine bias in the MED1-IDR is necessary for phase separation
Previous studies have implicated low complexity, intrinsically disordered regions of proteins 
in liquid-liquid phase separation (7, 36, 37, 43). An examination of the amino acid content 
of MED1 revealed that the IDR contains a striking compositional bias for serine (Fig. 6A). 
Interestingly, this serine compositional bias is conserved among vertebrates (Fig. 6B). To 
investigate whether this serine bias is necessary for the MED1 IDR’s capacity to phase 
separate, we mutated all the serine residues to alanine and investigated the ability of this 
mutated IDR to form phase-separated droplets in vitro. The MED1-IDR S-to-A mutant was 
incapable of forming phase-separated droplets under conditions where the wild type IDR 
readily formed droplets (Fig. 6C), indicating that the conserved serine bias in the MED1 
IDR is necessary for droplet formation.
MED1-IDR droplets can incorporate proteins necessary for transcription
A proposed function of phase separation at SEs is the ability to compartmentalize and 
concentrate factors within a biomolecular condensate, so we sought to test whether MED1-
IDR droplets could recapitulate this compartmentalization function in vitro. We identified 
conditions where the MED1-IDR could form droplets but the BRD4-IDR could not (Fig. 
S9). We then investigated whether the MED1-IDR droplets could compartmentalize BRD4-
IDR protein under these conditions (Fig. 7A). Using either mEGFP or mCherry fused 
proteins, we found that the MED1-IDR droplets (mCherry-fused) could incorporate, and 
thus concentrate, the BRD4-IDR protein (mEGFP-fused) (Fig. 7A). The MED1-IDR 
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droplets (mCherry-fused) did not incorporate mEGFP (Fig. 7A). To probe the approximate 
mesh size of the MED1-IDR droplet (48), we incubated MED1-IDR droplets with 
fluorescently-labeled dextrans of average molecular weights 4kDa, 10kDa, and 40kDa. We 
found that the 4kDa dextrans were incorporated into the MED1-IDR droplets, the 10kDa 
dextrans were incorporated with less efficiency, and the 40kDa dextrans were excluded (Fig. 
S10). These results suggest that the incorporation of mEGFP-BRD4-IDR (105 kDa) into the 
MED1-IDR droplet is due to attractive molecular interactions, as opposed to passive 
diffusion through the droplet mesh.
We next investigated whether the MED1-IDR, introduced into a transcription-competent 
nuclear extract, would form droplets that might incorporate BRD4 or other transcriptional 
components. We found that the wild type MED1-IDR but not the MED1-IDR S-to-A mutant 
formed droplets in these extracts (Fig. 7B). The MED1-IDR phase-separated droplets are 
denser than the surrounding extract and thus can be purified from solution by centrifugation. 
Immunoblot analysis revealed that BRD4 and the largest subunit of RNAPII (RPB1) were 
enriched in pelleted droplets in a MED1-IDR dose-dependent manner (Fig. 7C). These 
results indicate that the MED1-IDR droplets can incorporate BRD4 and RNAPII.
The ability of the MED1-IDR protein to incorporate BRD4 and RNAPII into an artificial 
phase-separated compartment suggests that it sequesters key components of the transcription 
apparatus and might thus be used to “squelch” transcription in the nuclear extract. We 
carried out an in vitro transcription assay with these extracts and found that the wild type 
MED1-IDR protein does indeed squelch transcription, correlating with the amount of 
material separated from solution by the MED1-IDR droplets (Fig. 7D). We did not observe 
these effects with equivalent concentrations of mEGFP or with the MED1-IDR S-to-A 
mutant (Fig. 7D). These results demonstrate that the MED1-IDR has the capacity to 
compartmentalize and concentrate transcriptional machinery from a complex nuclear extract.
Discussion
Super-enhancers (SEs) regulate genes with prominent roles in healthy and diseased cellular 
states (14, 15, 19–25, 49, 50). SEs and their components have been proposed to form phase-
separated condensates (30), but with no direct evidence. Here, we demonstrate that two key 
components of SEs, BRD4 and MED1, form nuclear condensates at sites of SE-driven 
transcription. Within these condensates, BRD4 and MED1 exhibit apparent diffusion 
coefficients similar to those previously reported for other proteins in phase-separated 
condensates in vivo (36, 37). The IDRs of both BRD4 and MED1 are sufficient to form 
phase-separated droplets in vitro and the MED1-IDR facilitates phase separation in living 
cells. Droplets formed by MED1-IDR are capable of concentrating transcription machinery 
in a transcriptionally competent nuclear extract. These results support a model in which 
transcriptional coactivators form phase-separated condensates that compartmentalize and 
concentrate the transcription apparatus at SE-regulated genes and identify SE components 
that likely play a role in phase separation.
SEs are established by the binding of master transcription factors (TFs) to enhancer clusters 
(14, 15). These TFs typically consist of a structured DNA binding domain and an 
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intrinsically disordered transcriptional activation domain (51–53). The activation domains of 
these TFs recruit high densities of many transcription proteins, which as a class are enriched 
for IDRs (54). While the exact client-scaffold relationship (55) between these components 
remains an open question, it is likely that these protein sequences mediate weak multivalent 
interactions thereby facilitating condensation. We propose that condensation of such high-
valency factors at SEs creates a reaction crucible within the separated dense phase, where 
high local concentrations of the transcriptional machinery ensure robust gene expression.
The nuclear organization of chromosomes is likely influenced by condensates at SEs. DNA 
interaction technologies indicate that the individual enhancers within the SEs have 
exceptionally high interaction frequencies with one another (16–18), consistent with the idea 
that condensates draw these elements into close proximity in the dense phase. Several recent 
studies suggest that SEs can interact with one another and may also contribute in this fashion 
to chromosome organization (56, 57). Cohesin, a Structural Maintenance of Chromosomes 
(SMC) protein complex, has been implicated in constraining SE-SE interactions because its 
loss causes extensive fusion of SEs within the nucleus (57). These SE-SE interactions may 
be due to a tendency of liquid phase condensates to undergo fusion (1–3).
The model that phase separation of coactivators compartmentalizes and concentrates the 
transcription apparatus at SEs and their regulated genes raises many questions. How does 
condensation contribute to regulation of transcriptional output? A study of RNAPII clusters, 
which may be phase-separated condensates, suggests a positive correlation between 
condensate lifetime and transcriptional output (58). What components drive formation and 
dissolution of transcriptional condensates? Our studies indicate that BRD4 and MED1 likely 
participate, but the roles of DNA-binding TFs, RNAPII and regulatory RNAs require further 
study. Why do some proteins, such as HP1a, contribute to phase-separated heterochromatin 
condensates (59, 60) and others contribute to euchromatic condensates? Studies to dissect 
the rules that govern partitioning into specific types of condensates have begun (61–65) and 
will need to be defined for proteins involved in transcriptional condensates. Does condensate 
misregulation contribute to pathological processes in disease and will new insights into 
condensate behaviors present new opportunities for therapy? Mutations within IDRs and 
misregulation of phase separation have already been implicated in a number of 
neurodegenerative diseases (66–68). Tumor cells have exceptionally large SEs at driver 
oncogenes that are not found in their cell of origin, and some of these are exceptionally 
sensitive to drugs that target SE components (22–25). How do we take advantage of phase 
separation principles established in physics and chemistry to more effectively improve our 
understanding of this form of regulatory biology? Addressing these questions at the 
crossroads of physics, chemistry, and biology will require collaboration across these diverse 
sciences.
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Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. BRD4 and MED1 form puncta at super-enhancers
(A) Immunofluorescence (IF) imaging of BRD4 and MED1 in mouse embryonic stem cells 
(mESC). Fluorescence signal is shown alone (left) and merged with Hoechst stain (right). 
(B) Live imaging of endogenously-tagged mEGFP-BRD4 and mEGFP-MED1 in mESC. (C) 
Depiction of Nanog locus, associated super-enhancers (black bars), DNA contacts (red arcs), 
BRD4 and MED1 ChIP-seq (green histograms), and location of FISH probes. (D) Co-
localization between BRD4 or MED1 and the Nanog locus by IF and DNA-FISH in fixed 
mESC. Separate images of the indicated IF and FISH are shown, along with an image 
showing the merged channels (overlapping signal in white). The blue line highlights nuclear 
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periphery, determined by Hoechst staining (not shown). The “Merge (zoom)” column 
displays region of image (yellow box) zoomed in for greater detail. (E) Averaged signal of 
either FISH, IF for BRD4, or IF for MED1 centered at Nanog DNA-FISH foci or randomly 
selected nuclear positions. (F) Co-localization between BRD4 or MED1 and the nascent 
RNA of Nanog by IF and RNA-FISH in fixed mESC. Data shown as in (D). (G) Averaged 
signal of either FISH, IF for BRD4, or IF for MED1 centered at Nanog RNA-FISH foci or 
randomly selected nuclear positions.
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Fig. 2. BRD4 and MED1 nuclear puncta exhibit properties expected for biomolecular 
condensates
(A) Representative images of FRAP experiment of mEGFP-BRD4 engineered mESCs. 
Yellow box highlights the punctum undergoing targeted bleaching. (B) Quantification of 
FRAP data for mEGFP-BRD4 puncta. Bleaching event occurs at t = 0s. For both bleached 
area and unbleached control, background-subtracted fluorescence intensities are plotted 
relative to a pre-bleach time point (t = −4s). Data are plotted as mean +/− SEM (N=9). (C) 
Same as (A) with mEGFP-MED1 engineered mESC cells. (D) Quantification of FRAP data 
Sabari et al. Page 15
Science. Author manuscript; available in PMC 2018 October 27.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
for mEGFP-MED1 puncta (N=9), same as (B). (E) Representative images of FRAP 
experiment of mEGFP-BRD4 engineered mESCs upon ATP-depletion. (F) Quantification of 
FRAP data of mEGFP-BRD4 upon ATP-depletion (N=8), same as (B). (G) Representative 
images of FRAP experiment of mEGFP-MED1 engineered mESC cells upon ATP depletion. 
(H) Quantification of FRAP data for mEGFP-MED1 puncta upon ATP-depletion (N=8), 
same as (B). Images were taken using the Zeiss LSM 880 confocal microscope with 
Airyscan detector with 63x objective at 37°C.
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Fig. 3. 1,6-hexanediol disrupts BRD4 and MED1 puncta and disrupts BRD4, MED1, and 
RNAPII occupancy at super-enhancers and super-enhancer driven genes.
(A) Representative images of mEGFP-BRD4 or mEGP-MED1 engineered mESCs before 
and after treatment with 3% hexanediol for 15 seconds. (B) Box plot presentation of the fold 
change in number of mEGFP-BRD4 or mEGFP-MED1 puncta observed before and after 
addition of vehicle or 1,6-hexanediol to a final concentration of 3%. (C) Genome browser 
view of BRD4 (blue), MED1 (red), and RNAPII (brown) ChIP-seq data from untreated or 
1,6-hexanediol treated (1.5% for 30 minutes) mESCs at the Klf4 locus. (D) Box plot 
representation of log2 fold-change in BRD4 (blue), MED1 (red), and RNAPII (brown) 
ChIP-seq read density (1,6-hexanediol versus untreated) for regions defined as super-
enhancers (SEs) or typical enhancers (TEs) (see methods and Table S2). (E) Boxplot 
representation of log2 fold-change in RNAPII ChIP-seq density (1,6-hexanediol versus 
untreated) within the gene body (transcription start site to transcription end site) of all active 
genes (RPKM>1), typical-enhancer associated genes (TE genes) or super-enhancer 
associated genes (SE genes). (F) Gene Set Enrichment Analysis of genes, ranked by their 
log2 fold-change in RNAPII ChIP-seq density within the gene body and annotated against 
the set of super-enhancer-associated genes. Enrichment score profile and position of SE-
associated genes is shown.
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Fig. 4. Intrinsically disordered regions (IDRs) of BRD4 and MED1 phase separate in vitro
(A) Graphs plotting intrinsic disorder (PONDR VSL2) for BRD4 and MED1. PONDR 
VSL2 score (y-axis) and amino acid position (x-axis) are shown. Purple bar designates the 
IDR under investigation. (B) Schematic of recombinant mEGFP fusion proteins used here. 
Purple boxes indicate IDR’s of BRD4 (BRD4-IDR) and MED1 (MED1-IDR) shown in (A). 
(C) Visualization of turbidity associated with droplet formation. Tubes containing BRD4-
IDR (left pair), MED1-IDR (middle pair) or GFP (right pair) in the presence (+) or absence 
(−) of PEG-8000 are shown. Blank tubes included between pairs for contrast. (D) 
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Representative images of droplet formation at different protein concentrations. BRD4-IDR, 
MED1-IDR or mEGFP were added to droplet formation buffer to final concentrations 
indicated. (E) Representative images of droplet formation at different salt concentrations. 
BRD4-IDR or MED1-IDR was added to droplet formation buffer to achieve 10 μM protein 
concentration with a final NaCl concentration as indicated. (F) Representative images of 
droplet reversibility experiment. BRD4-IDR (top row) or MED1-IDR (bottom row) BRD4-
IDR or MED1-IDR, as indicated, (20 μM protein, 75 mM NaCl) (initial) or followed by a 
1:1 dilution (diluted 1/2) or a 1:1 dilution with an increase to 425mM NaCl (diluted 1/2 + 
NaCl)
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Fig. 5. The IDR of MED1 participates in phase separation in cells
(A) Schematic of optoIDR assay, depicting recombinant protein with intrinsically disordered 
domain (purple), mCherry (red) and Cry2 (orange) expressed in cells exposed to blue light. 
(B and C) Images of NIH3T3 cells expressing either (B) mCherry-Cry2 or (C) a portion of 
the MED1 IDR (amino acids 948–1157) fused to mCherry-Cry2 (MED1-optoIDR). Cells 
were subjected to laser excitation every 2 seconds for indicated time. (D) Time-lapse images 
of the nucleus of an NIH3T3 cell expressing MED1-optoIDR subjected to laser excitation 
every 2 seconds for the times indicated. A droplet fusion event occurs in the region 
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highlighted by the yellow box. (E) Droplet fusion event highlighted in (D) at higher 
resolution and extended times as indicated. (F) Image of a MED1-optoIDR optoDroplet 
(yellow box) before (left), during (middle) and after (right) photobleaching. The blue box 
highlights an unbleached region for comparison. Time relative to photobleaching (0”) is 
indicated. (G) Signal intensity relative to pre-bleaching signal (y-axis) and time relative to 
photobleaching (x-axis) are shown. Data shown as average relative intensity ± SD (n=15). 
(H) Time-lapse and close-up view of droplet recovery for regions highlighted in (F). Times 
relative to photobleaching are indicated. Scale bar, 1 μm.
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Fig. 6: Conserved serine bias is necessary for MED1-IDR phase separation
(A) Amino acid composition of the MED1 protein. Each row represents information for a 
single amino acid, single letter amino code shown on right. The length of the row 
corresponds to the length of the MED1 protein. Black bars represent occurrence of indicated 
amino acid at that position in MED1. Purple bar represents the IDR of MED1 under 
investigation. (B) Serine composition of MED1 protein from indicated organisms. Presented 
as in (A). (C) Mutating all serines to alanine disrupts phase separation. Representative 
images of wild type MED1-IDR or all serines to alanine mutant MED1-IDR (MED1-IDR S-
to-A mutant) fused to mEGFP in droplet formation assay (10uM protein, 125mM NaCl, 
10% Ficoll-400).
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Fig. 7: MED1-IDR droplets compartmentalize and concentrate proteins necessary for 
transcription
(A) MED1-IDR droplets incorporate BRD4-IDR protein in vitro. The indicated mEGFP or 
mCherry fusion proteins were mixed at 10μM each in Buffer D containing 10% Ficoll-400 
and 125mM NaCl. Indicated fluorescence channels are presented for each mixture. 
Illustrations summarizing results shown on left. (B) MED1-IDR forms droplets in an in vitro 
transcription reaction containing HeLa cell nuclear extract, while the MED1-IDR S-to-A 
mutant does not. Representative images of indicated mEGFP-fusion protein when added to 
an in vitro transcription reaction containing HeLa cell nuclear extract at a final concentration 
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of 3mg/ml (see Materials and Methods for complete list of components). (C) MED1-IDR 
droplets compartmentalize transcriptional machinery from a nuclear extract. Immunoblots of 
the pellet fraction of indicated protein added to in vitro transcription reactions (as in B). 
Illustration of a proposed model of molecular interactions taking place within MED1-IDR 
droplets in the nuclear extract is presented to the right. (D) MED1-IDR droplets 
compartmentalize machinery necessary for the in vitro transcription reaction. 
Autoradiograph of radiolabelled RNA products of in vitro transcription reactions under 
indicated conditions. Arrow indicates expected RNA product. Reactions conducted as in 
(69) with minor modifications. See Materials and Methods for full details. Illustration of a 
proposed model of molecular interactions taking place within MED1-IDR droplets in 
nuclear extract and the impact on in vitro transcription reaction is presented to the right.
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